Insulin aspart, recombinant Subcutaneous and Zolmitriptan Tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Zolmitriptan Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: zolmitriptan
Brand name: Zomig, Zomig-ZMT
Synonyms: Zolmitriptan, ZOLMitriptan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Zoloft
- Insulin aspart, recombinant Subcutaneous-Zoloft (Sertraline Oral Liquid)
- Insulin aspart, recombinant Subcutaneous-Zoloft (Sertraline Tablets)
- Insulin aspart, recombinant Subcutaneous-Zolpidem
- Insulin aspart, recombinant Subcutaneous-Zolpidem Extended Release
- Insulin aspart, recombinant Subcutaneous-Zolpidem Extended-Release Tablets
- Zolmitriptan Tablets-Insulin degludec
- Zolmitriptan Tablets-Insulin Degludec (U-100) Prefilled Pens
- Zolmitriptan Tablets-Insulin Degludec (U-100) Vials
- Zolmitriptan Tablets-Insulin Degludec (U-200) Prefilled Pens
- Zolmitriptan Tablets-Insulin degludec and liraglutide
- Zolmitriptan Tablets-Insulin degludec and liraglutide Subcutaneous